Expression of the costimulatory receptor CD30 is regulated by both CD28 and cytokines

Journal of Immunology

Volumn 160, Issue 5, 1998, Pages 2180-2187

  Gilffillan, Molly C ^a,b   Noel, Patricia J ^b   Podack, Eckhard R ^c   Reiner, Steven L ^a,b   Thompson, Craig B ^a,b  

^a UNIVERSITY OF CHICAGO   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

^c UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD28 ANTIGEN; CD30 ANTIGEN; INTERLEUKIN 4;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL CULTURE; CELL MATURATION; CROSS LINKING; FLOW CYTOMETRY; GENE EXPRESSION; GENE EXPRESSION REGULATION; IMMUNE RESPONSE; LYMPHOCYTE ACTIVATION; LYMPHOCYTE FUNCTION; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ANIMALS; ANTIGENS, CD28; ANTIGENS, CD30; CYTOKINES; IMMUNIZATION, SECONDARY; IMMUNOSUPPRESSIVE AGENTS; INTERLEUKIN-13; INTERLEUKIN-4; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; RECEPTORS, ANTIGEN, T-CELL; RECEPTORS, TUMOR NECROSIS FACTOR; RECOMBINANT PROTEINS; SIGNAL TRANSDUCTION; T-LYMPHOCYTES; UP-REGULATION;

EID: 0032031410     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. Harding, F. A., J. G. McArthur, J. A. Gross, D. H. Raulet, and J. P. Allison. 1992. CD28-mediated signalling co-stimulates murine T cells and prevents induction of anergy in T-cell clones. Nature 356:607.
2. Lenschow, D. J., T. L. Walunas, and J. A. Bluestone. 1996. CD28/B7 system of T cell costimulation. Annu. Rev. Immunol. 14:233.
3. Lucas, P. J., I. Negishi, K.-i. Nakayama, L. E. Fields, and D. Y. Loh. 1995. Naive CD28-deticient T cells can initiate but not sustain an in vitro antigen-specific immune response. J. Immunol. 154:5757.
4. Noel, P. J., L. H. Boise, J. M. Green, and C. B. Thompson. 1996. CD28 costimulation prevents cell death during primary T cell activation. J. Immunol. 157:636.
5. Baker, S. J. and E. P. Reddy. 1996. Transducers of life and death: TNF receptor superfamily and associated proteins. Oncogene 12:1.
6. Gruss, H.-J. and S. K. Dower. 1995. Tumor necrosis factor ligand superfamily: involvement in the pathology of malignant lymphomas. Blood 85:3378.
7. Kehry, M. R. 1996. CD40-mediated signaling in B cells: balancing cell survival, growth, and death. J. Immunol. 156:2345.
8. Foy, T. M., A. Aruffo, J. Bajorath, J. E. Buhlmann, and R. J. Noelle. 1996. Immune regulation by CD40 and its ligand gp39. Annu. Rev. Immunol 14:591.
9. L, Cdk4, and Cdk6. J. Immunol. 155:5527.
10. L, and CD40 in WEHI-231 cells. J. Immunol. 155:3830.
11. Gedrich, R. W., M. C. Gilfillan, C. S. Duckett, J. L. Van Dongen, and C. B. Thompson. 1996. CD30 contains two binding sites with different specificities for members of the tumor necrosis factor receptor-associated factor family of signal transducing proteins. J. Biol. Chem. 271:12852.
12. Duckett, C. S., R. W. Gedrich, M. C. Gilfillan, and C. B. Thompson. 1997. Induction of nuclear factor κB by the CD30 receptor is mediated by TRAF1 and TRAF2. Mol. Cell Biol. 17:1535.
13. Ansieau, S., I. Schieffrahn, G. Mosialos, H. Brand, J. Duyster, K. Kaye, J. Harada, B. Dougall, G. Hubinger, E. Kieff, F. Herrmann, A. Leutz, and H.-J. Gruss. 1996. Tumor necrosis factor receptor-associated factor (TRAF)-1. TRAF-2. and TRAF-3 interact in vivo with the CD30 cytoplasmic domain: TRAF-2 mediates CD30-induced nuclear factor κB activation. Proc. Natl. Acad. Sci. USA 93:14053.
14. Ishida, T., S.-i. Mizushima, S. Azuma, N. Kobayashi, T. Tojo, K. Suzuki, S. Aizawa, T. Watanabe, G. Mosialos, E. Kieff, T. Yamamoto, and J.-i. Inoue. 1996. Identification of TRAF6, a novel tumor necrosis factor receptor-associated factor protein that mediates signaling from an amino-terminal domain of the CD40 cytoplasmic region. J. Biol. Chem. 271:28745.
15. Gruss, H.-J., D. Ulrich, S. Braddy, R. J. Armitage, and S. K. Dower. 1995. Recombinant CD30 ligand and CD40 ligand share common biological activities on Hodgkin and Reed-Sternberg cells. Eur. J. Immunol. 25:2083.
16. Gruss, H.-J., N. Boiani, D. E. Williams, R. J. Armitage, C. A. Smith, and R. G. Goodwin. 1994. Pleiotropic effects of the CD30 ligand on CD30-expressing cells and lymphoma cell lines. Blood 83:2045.
17. Smith, C. A., H.-J. Gruss, T. Davis, D. Anderson, T. Farrah, E. Baker, G. R. Sutherland, C. I. Brannan, N. G. Copeland, N. A. Jenkins, K. H. Grabstein, B. Gliniak, I. B. McAlister, W. Fanslow, M. Alderson, B. Falk, S. Gimpel, S. Gillis, W. S. Din, R. G. Goodwin, and R. J. Armitage. 1993. CD30 antigen, a marker for Hodgkin's lymphoma, is a receptor whose ligand defines an emerging family of cytokines with homology to TNF. Cell 73:1349.
18. Bowen, M. A., R. K. Lee, G. Miragliotta, S. Y. Nam, and E. R. Podack. 1996. Structure and expression of murine CD30 and its role in cytokine production. J. Immunol. 156:442.
19. Amakawa, R., A. Hakem, T. M. Kundig, T. Matsuyama, J. J. L. Simard, E. Timms, A. Wakeham, H.-W. Mittruecker, H. Griesser, H. Takimoto, R. Schmits, A. Shahinian, P. S. Ohashi, J. M. Penninger, and T. W. Mak. 1996. Impaired negative selection of T cells in Hodgkin's disease antigen CD30-deficient mice. Cell 84:551.
20. Lee, S. Y., C. G. Park, and Y. Choi. 1996. T Cell Receptor-dependent cell death of T cell hybridomas mediated by the CD30 cytoplasmic domain in association with tumor necrosis factor receptor-associated factors. J. Exp. Med. 183:669.
21. Bowen, M. A., K. J. Olsen, L. Cheng, D. Avila, and E. R. Podack. 1993. Functional effects of CD30 on a large granular lymphoma cell line, YT. J. Immunol. 151:5896.
22. Tartaglia, L. A., D. V. Goeddel, C. Reynolds, I. S. Figari, R. F. Weber, B. M. Fendly, and M. A. Palladino Jr. 1993. Stimulation of human T-cell proliferation by specific activation of the 75-kDa tumor necrosis factor receptor. J. Immunol. 151:4637.
23. Sheehan, K. C. F., J. K. Pinckard, C. D. Arthur, L. P. Dehner, D. V. Goeddel, and R. D. Schreiber. 1995. Monoclonal antibodies specific for murine p55 and p75 tumor necrosis factor receptors: identification of a novel in vivo role for p75. J. Exp. Med. 181:607.
24. Zheng, L., G. Fisher, R. E. Miller, J. Peschon, D. H. Lynch, and M. J. Lenardo. 1995. Induction of apoptosis in mature T cells by tumor necrosis factor. Nature 377:348.
25. Hamann, D., C. M. U. Hilkens, J. L. Grogan, S. M. A. Lens, M. L. Kapsenberg, M. Yazdanbakhsh, and R. A. W. van Lier. 1996. CD30 expression does not discriminate between human Th1- and Th2-type T cells. J. Immunol. 156:1387.
26. + T cells. J. Immunol. 151:2380.
27. Shahinian, A., K. Pfeffer, K. P. Lee, T. M. Kundig, K. Kishihara, A. Wakeham, K. Kawai, P. S. Ohashi, C. B. Thompson, and T. W. Mak. 1993. Differential T cell costimulatory requirements in CD28-deficient mice. Science 261:609.
28. Green, J. M., P. J. Noel, A. I. Sperling, T. L. Walunas, G. S. Gray, J. A. Bluestone, and C. B. Thompson. 1994. Absence of B7-dependent responses in CD28-deficient mice. Immunity 1:501.
29. Bluestone, J. A. 1995. New Perspectives of CD28-B7-mediated T cell costimulation. Immunity 2:555.
30. + cells. Eur. J. Immunol. 25:587.
31. Brown, D. R., J. M. Green, N. H. Moskowitz, M. Davis, C. B. Thompson, and S. L. Reiner. 1996. Limited role of CD28-mediated signals in T helper subset differentiation. J. Exp. Med. 184:803.
32. Thompson, C. B., T. Lindsten, J. A. Ledbetter, S. L. Kunkel, H. A. Young, S. G. Emerson, J. M. Leiden, and C. H. June. 1989. CD28 activation pathway regulates the production of multiple T-cell-derived lymphokines/cytokines. Proc. Natl. Acad. Sci. USA 86:1333.
33. Seder, R. A., R. N. Germain, P. S. Linsley, and W. E. Paul. 1994. CD28-mediated costimulation of interleukin 2 (IL-2) production plays a critical role in T cell priming for IL-4 and interferon γ production. J. Exp. Med. 179:299.
34. Minty, A., P. Chalon, J.-M. Derocq, X. Dumont, J.-C. Guillemot, M. Kaghad, C. Labit, P. Leplatois, P. Liauzun, B. Miloux, C. Minty, P. Casellas, G. Loison, J. Lupker, D. Shire, P. Ferrara, and D. Caput. 1993. Interleukin-13 is a new human lymphokine regulating inflammatory and immune responses. Nature 362:248.
35. Keegan, A., J. A. Johnston, P. J. Tortolani, L. J. McReynolds, C. Kinzer, J. J. O'Shea, and W. E. Paul. 1995. Similarities and differences in signal transduction by interleukin 4 and interleukin 13: analysis of Janus kinase activation. Proc. Natl. Acad. Sci. USA 92:7681.
36. Malabarba, M. G., H. Rui, H. H. J. Deutsch, J. Chung, F. S. Kalthoff, W. L. Farrar, and R. A. Kirken. 1996. Interleukin-13 is a potent activator of JAK3 and STAT6 in cells expressing interleukin-2 receptor-γ and interleukin-4 receptor-α. Biochem. J. 319:865.
37. DeFrance, T., P. Carayon, G. Billian, J.-C. Guillemot, A. Minty, D. Caput, and P. Ferrara. 1994. Interleukin 13 is a B cell stimulating factor. J. Exp. Med. 179:135.
38. + T cells by IL-4 and IFN-γ. J. Immunol. 158:2090.
39. McArthur, J. B. and D. H. Raulet. 1993. CD28-induced costimulation of T helper type 2 cells mediated by induction of responsiveness to interleukin 4. J. Exp. Med. 178:1645.
40. + T helper type 1 cells requires costimulation. J. Immunol. 149:901.
41. + T cells producing Th2-type cytokines. FASEB J. 9:81.
42. Romagnani, S., G. Del Prete, E. Maggi, M. Chilosi, F. Caligaris-Cappio, and G. Pizzolo. 1995. CD30 and type 2 T helper (Th2) responses. J. Leukocyte Biol. 57:726.
43. Hurtado, J. C., Y.-J. Kim, and B. S. Kwon. 1997. Signals through 4-1BB are costimulatory to previously activated splenic T cells and inhibit activation-induced cell death. J. Immunol. 158:2600.
44. - T lymphocytes by 4-1BB ligand. J. Immunol. 158:551.
45. + T cell proliferation and lead to the amplification in vivo of cytotoxic T cell responses. J. Exp. Med. 186:47.
46. Lee, S. Y., S. Y. Lee, G. Kandala, M.-L. Liou, H.-C. Liou, and Y. Choi. 1996. CD30/TNF receptor-associated factor interaction: NF-κB activation and binding specificity. Proc. Natl. Acad. Sci. USA 93:9699.
47. Tsitsikov, E. N., D. A. Wright, and R. S. Geha. 1997. CD30 induction of human immunodeficiency virus gene transcription is mediated by TRAF2. Proc. Natl. Acad. Sci. USA 94:1390.
48. Foy, T. M., D. M. Page, T. J. Waldschmidt, A. Schoneveld, J. D. Laman, S. R. Masters, L. Tygrett, J. A. Ledbetter, A. Aruffo, E. Classen, J. C. Xu, R. A. Flavell, S. Oehen, S. M. Hedrick, and R. J. Noelle. 1995. An essential role for gp39, the ligand for CD40, in thymic selection. J. Exp. Med. 182:1377.
49. Ashton-Rickardt, P. G., A. Bandiera, J. R. Delaney, L. Van Kaer, H.-P. Pircher, R. M. Zinkernagel, and S. Tonegawa. 1994. Evidence for a differential avidity model of T cell selection in the thymus. Cell 76:651.
50. Smith, C. A., G. T. Williams, R. Kingston, E. J. Jenkinson, and J. J. T. Owen. 1989. Antibodies to CD3/T-cell receptor complex induce death by apoptosis in immature T cells in thymic cultures. Nature 337:181.
51. Schattner, E. J., K. B. Elkon, D.-H. Yoo, J. Tumang, P. H. Krammer, M. K. Crow, and S. M. Friedman. 1995. CD40 ligation induces Apo-1/Fas expression on human B lymphocytes and facilitates apoptosis through the Apo-1/Fas pathway. J. Exp. Med. 182:1557.
52. Rathmell, J. C., S. E. Townsend, J. C. Xu, R. A. Flavell, and C. C. Goodnow. 1996. Expansion or elimination of B cells in vivo: dual roles for CD40- and Fas (CD95)-ligands modulated by the B cell antigen receptor. Cell 87:319.